ARROWSTREET CAPITAL, LIMITED PARTNERSHIP - CORCEPT THERAPEUTICS INC ownership

CORCEPT THERAPEUTICS INC's ticker is CORT and the CUSIP is 218352102. A total of 221 filers reported holding CORCEPT THERAPEUTICS INC in Q4 2018. The put-call ratio across all filers is 1.93 and the average weighting 0.1%.

Quarter-by-quarter ownership
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP ownership history of CORCEPT THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$30,119
+378.0%
1,105,469
+290.4%
0.04%
+350.0%
Q2 2023$6,301
+2777.2%
283,190
+2705.8%
0.01%
Q1 2023$219
-53.2%
10,093
-56.2%
0.00%
-100.0%
Q4 2022$468
-99.9%
23,048
+63.0%
0.00%
Q1 2022$318,000
-96.7%
14,142
-97.1%
0.00%
-100.0%
Q4 2021$9,725,000
-66.8%
491,162
-67.0%
0.01%
-67.6%
Q3 2021$29,314,000
+109.5%
1,489,544
+134.2%
0.04%
+117.6%
Q2 2021$13,991,000
-43.8%
635,968
-39.3%
0.02%
-48.5%
Q1 2021$24,914,000
-7.0%
1,047,263
+2.3%
0.03%
-13.2%
Q4 2020$26,786,000
+63.8%
1,023,936
+9.0%
0.04%
+46.2%
Q3 2020$16,350,000
+4.4%
939,408
+0.9%
0.03%
-10.3%
Q2 2020$15,659,000
+11.1%
930,953
-21.5%
0.03%
-27.5%
Q1 2020$14,098,000
-17.5%
1,185,737
-16.1%
0.04%0.0%
Q4 2019$17,093,000
+363.1%
1,412,627
+349.3%
0.04%
+344.4%
Q1 2019$3,691,000
+24.0%
314,400
+41.1%
0.01%
+12.5%
Q4 2018$2,976,000
-77.7%
222,750
-73.8%
0.01%
-75.8%
Q2 2018$13,362,000
-2.9%
849,978
+1.6%
0.03%
+3.1%
Q1 2018$13,757,000
+40.7%
836,280
+54.5%
0.03%
+33.3%
Q4 2017$9,779,000
-18.8%
541,446
-13.3%
0.02%
-25.0%
Q3 2017$12,049,000
+928.1%
624,275
+528.7%
0.03%
+700.0%
Q2 2017$1,172,000
-54.2%
99,300
-57.5%
0.00%
-55.6%
Q1 2017$2,558,000233,3930.01%
Other shareholders
CORCEPT THERAPEUTICS INC shareholders Q4 2018
NameSharesValueWeighting ↓
INGALLS & SNYDER LLC 8,712,176$123,147,0006.01%
TANAKA CAPITAL MANAGEMENT INC 74,139$1,048,0003.38%
S&T BANK/PA 625,078$8,859,0001.92%
Parallel Advisors, LLC 1,277,851$18,062,0001.55%
AJ WEALTH STRATEGIES, LLC 595,828$8,422,0001.11%
Matarin Capital Management, LLC 891,636$12,603,0000.95%
Capital Impact Advisors, LLC 162,544$2,370,0000.90%
AMI ASSET MANAGEMENT CORP 775,685$10,964,0000.57%
Birchview Capital, LP 50,000$707,0000.47%
Zebra Capital Management LLC 25,409$359,0000.39%
View complete list of CORCEPT THERAPEUTICS INC shareholders